The GSEA result of IGF2BP2 showed that it is significantly related to metastasis, CREBBP targets, docetaxel resistance, hypoxia, BRCA1 targets, base excision repair, TAP63 pathway, etoposide sensitivity, epithelial mesenchymal transition, gemcitabine resistance, cisplatin resistance, gefitinib resistance, tumor differentiated well vs. poorly, and SFRP2 targets. This evidence concerns the gene BRCA1 and neoplasm.